Literature DB >> 1471712

Telomere reduction in endometrial adenocarcinoma.

J K Smith1, G Yeh.   

Abstract

OBJECTIVE: Some of the genomic instability that is observed in solid tumors may be due to the loss of telomeric sequences. These experiments were designed to compare the number of telomeric repeat sequences in endometrial adenocarcinoma with that found in adjacent normal tissue. STUDY
DESIGN: Deoxyribonucleic acid was extracted from normal and malignant uterine tissue of 11 patients undergoing hysterectomy for treatment of endometrial adenocarcinoma and also from five endometrial carcinoma cell lines. The relative number of telomeric repeat sequences in each sample was measured by hybridization of these deoxyribonucleic acids to a probe specific for the human telomeric repeat. Hybridization signals were quantified by autoradiography and a beta-particle detection system.
RESULTS: A reduction of telomeric repeat sequences in tumor versus normal tissue was found in 10 of 11 cases. Telomere reduction was also seen in endometrial carcinoma cell lines.
CONCLUSIONS: Telomere reduction is a genetic characteristic of many endometrial tumors. Telomere reduction may contribute to the genesis and progression of endometrial carcinoma, or it may be a secondary effect of the tumorigenesis process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471712     DOI: 10.1016/0002-9378(92)91791-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Telomere length and genetic analyses in population-based studies of endometrial cancer risk.

Authors:  Jennifer Prescott; Monica McGrath; I-Min Lee; Julie E Buring; Immaculata De Vivo
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

2.  Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells.

Authors:  A J Klingelhutz; S A Barber; P P Smith; K Dyer; J K McDougall
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

3.  Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide.

Authors:  S Sugihara; K Mihara; T Marunouchi; H Inoue; M Namba
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

4.  Telomeric DNA in normal and leukemic blood cells.

Authors:  O Yamada; K Oshimi; T Motoji; H Mizoguchi
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 5.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

Review 6.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

7.  Telomerase activity in human ovarian carcinoma.

Authors:  C M Counter; H W Hirte; S Bacchetti; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 8.  Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.

Authors:  Lynnette R Ferguson; Helen Chen; Andrew R Collins; Marisa Connell; Giovanna Damia; Santanu Dasgupta; Meenakshi Malhotra; Alan K Meeker; Amedeo Amedei; Amr Amin; S Salman Ashraf; Katia Aquilano; Asfar S Azmi; Dipita Bhakta; Alan Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Hiromasa Fujii; Gunjan Guha; Dorota Halicka; William G Helferich; W Nicol Keith; Sulma I Mohammed; Elena Niccolai; Xujuan Yang; Kanya Honoki; Virginia R Parslow; Satya Prakash; Sarallah Rezazadeh; Rodney E Shackelford; David Sidransky; Phuoc T Tran; Eddy S Yang; Christopher A Maxwell
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 17.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.